TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Don't Miss
Advertisement

Australian researcher develops Covid vax for animals

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

Canberra, March 4

Advertisement

A South Australian researcher has developed a coronavirus vaccine for animals that will soon be trialed on pets.

Advertisement

Nikolai Petrovsky, a professor at Flinders University, and veterinarian Sam Kovac joined forces to adapt COVAX-19 for animals, reports Xinhua news agency.

Developed by Petrovsky, COVAX-19 has been administered to millions of people in Iran and is awaiting human approval in Australia.

Kovac’s three dogs will be among 25 pets that participate in trials of the vaccine.

Advertisement

“The great thing is that being based on a human vaccine technology where more than 6 million doses have been safely administered, we can be confident it is also very safe for pets,” he said. 

“Unlike other respiratory viruses, it is now proven that many domestic pets including cats, dogs and pocket pets like ferrets can catch Covid-19 from human close contacts. Just like us, they can catch it via direct contact and handling by an infected human.

“They are at risk of myocarditis, pericarditis, respiratory failure, but may also just have a mild or asymptomatic infection,” he said.

“(Unapproved RATs) have not been assessed by the TGA, meaning they do not come with the same assurances of safety, effectiveness and quality as those that have met Australian regulatory requirements.

“Unapproved versions may not work as expected, or work at all,” the TGA said. IANS

Advertisement
Show comments
Advertisement